Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab — Emanuela Palmerini (2021) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
Shared by
Jean Yves Blay
Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
Article
2021
en
Authors
+7 more
EP
Emanuela Palmerini
LS
Leanne L. Seeger
MG
Marco Gambarotti
Abstract
1 min read
clinicaltrials.gov , ( NCT00680992 ). Registered May 20, 2008.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Preprint
2023
Data from Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of Bone
Daniel Branstetter
,
Scott D. Nelson
,
J. Carlos Manivel
,
Jean Yves Blay
,
Sant P. Chawla
,
David M. Thomas
,
Susie Jun
,
Ira Jacobs
Preprint
2023
Data from Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of Bone
Daniel Branstetter
,
Scott D. Nelson
,
J. Carlos Manivel
,
Jean Yves Blay
,
Sant P. Chawla
,
David M. Thomas
,
Susie Jun
,
Ira Jacobs
Preprint
2023
Supplementary Figure Legend from Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of Bone
Daniel Branstetter
,
Scott D. Nelson
,
J. Carlos Manivel
,
Jean Yves Blay
,
Sant P. Chawla
,
David M. Thomas
,
Susie Jun
,
Ira Jacobs
Preprint
2023
Supplementary Figure Legend from Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of Bone
Daniel Branstetter
,
Scott D. Nelson
,
J. Carlos Manivel
,
Jean Yves Blay
,
Sant P. Chawla
,
David M. Thomas
,
Susie Jun
,
Ira Jacobs
Preprint
2023
Supplementary Figure 1 from Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of Bone
Daniel Branstetter
,
Scott D. Nelson
,
J. Carlos Manivel
,
Jean Yves Blay
,
Sant P. Chawla
,
David M. Thomas
,
Susie Jun
,
Ira Jacobs
Discussion(0)
No comments yet. Be the first to comment.